Moleculin Biotech, Inc. (NASDAQ: MBRX) is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company’s lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. Annamycin is currently in development for the treatment of soft tissue sarcoma (STS) lung metastases and relapsed or refractory acute myeloid leukemia (AML). Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of COVID-19 and other viruses, as well as cancer indications including brain tumors, pancreatic and other cancers. Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers, and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma.
View Top Employees from Moleculin Biotech, Inc.Website | http://www.moleculin.com |
Ticker | MBRX |
Revenue | $1 million |
Employees | 23 (22 on RocketReach) |
Founded | 2006 |
Address | 5300 Memorial Dr Suite 950, Houston, Texas 77030, US |
Phone | (713) 300-5160 |
Technologies |
JavaScript,
HTML,
PHP
+18 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals for dermatology, Pharmaceuticals, Science and Engineering, Healthcare, Medical, Health Care, Pharmaceutical |
Web Rank | 4 Million |
Keywords | Moleculin Biotech, Mbrx, Moleculin Biotech Inc, Annamycin, Mbrx News |
Competitors | Evgen Pharma, Isofol Medical AB (publ), NeurOp, Inc., Phosplatin Therapeutics, Praetego |
SIC | SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 37 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 33 Companies, NAICS Code 5417 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Moleculin Biotech, Inc. employee's phone or email?
The Moleculin Biotech, Inc. annual revenue was $1 million in 2024.
22 people are employed at Moleculin Biotech, Inc..
Moleculin Biotech, Inc. is based in Houston, Texas.
The NAICS codes for Moleculin Biotech, Inc. are [325, 33, 5417, 541711, 54, 32, 541, 54171].
The SIC codes for Moleculin Biotech, Inc. are [87, 28, 37, 283].